The phrase "absorption cmax" is correct and usable in written English, particularly in scientific or pharmacological contexts.
You can use it when discussing the maximum concentration of a drug in the bloodstream after absorption.
Example: "The study measured the absorption cmax to determine the efficacy of the new medication."
Alternatives: "peak plasma concentration" or "maximum absorption concentration."
The rate (Tmax) and extent of absorption (Cmax) of granisetron from APF530 were generally dose proportional and consistent between the two studies.
There was a slight but clinically nonsignificant reduction in the rate of absorption (Cmax,ss GMR 88.3%; 90% CI: 78.8%–98.9%) of empagliflozin.
The difference in bioavailability between the two drugs should ideally lie within the therapeutic bioequivalence interval (the 90%% confidence interval of the ratio of a log-transformed test to reference mean area under the curve (AUC), which shows drug absorption, and maximum plasma level during drug absorption (Cmax) values falling within the range of 80 125%%) [ 4].
Area under the curve (AUC) concentration measurements act as a marker for the extent of absorption, while peak concentration (Cmax) and time to Cmax (tmax) characterize the rate of absorption.
The absorption of diclofenac can be inconsistent, with variable maximum plasma concentration (Cmax) and time to Cmax (tmax), as well as the presence of late or secondary plasma peaks in plots of diclofenac concentration versus time [ 73– 73].
For acetaminophen absorption, PK parameters estimated from plasma concentration (Days 0 and 10) included area under the plasma concentration versus time curve (AUC) from time 0 to the last measurable concentration (AUC0 last) and extrapolated to infinity (AUC0 inf), maximum plasma concentration (Cmax), and time to Cmax (tmax).
Plasma lispro measurements were used to estimate absorption rate constant (ka), maximum plasma concentration (Cmax), time to maximal concentration (Tmax), area under the lispro plasma concentration curve (AUC0-∞), Cmax to dose ratio (Cmax/ D), AUC0-∞ to dose ratio (AUC0-∞/ D), volume of distribution (Vz), clearance (Cl), half-life (t½), and mean residence time.
As shown in the time-course profile in Figure 5, the pharmacokinetic profile of T-20-XTEN-4 was characterized by an absorption phase which led to a maximum plasma concentration Cmax of 11.1 mg/mL at 24 h, followed by a linear elimination phase.
Bioavailability of metformin, estimated from the amount of metformin excreted in the urine over 24 h; AUC of metformin absorption from 0 24 h (AUC0 24 h); Time to peak drug concentration (Tmax) and peak plasma drug concentration (Cmax); and AUC of plasma glucose levels over the first 8 h of sampling (AUC0 8h).
The immediate release (core) tablets disintegrated very fast in GI tract and resulted in quick absorption of the drug from upper GIT and producing peak plasma concentration Cmax of 15677.52 ng/mL at 3 h Tmax.
Pharmacokinetic analysis showed rapid absorption with Cmax reached on average 1 2 h earlier in case of the solution.
